Techcyte, a leader in AI-powered digital pathology, announced the launch of Fusion, the first open, standards-based, SaaS platform designed to unify anatomic and clinical pathology workflows. By ...

Motive, the AI Platform for Physical Operations, today announced it has been named to G2's 2025 Best Software Awards, placing #1 on the Best Supply Chain and Logistics Products list, and landing at #4 ...

TruScreen Group Limited (“TruScreen” or “the Company”) advises that its CEO, Marty Dillon is an invited presenter at the Healthcare Day Forum held in Singapore on Monday March 24, 2025. Mr Dillon’s ...

Several health systems across the US are gearing up to try a new way of drawing blood: using a robot.Health systems have agreed to be part of a clinical trial of a device that automates blood ...

Mattiedna Johnson was a nurse, laboratory technician, and medical researcher who revolutionize modern antibiotic treatments.

Unlike with a traditional blood draw, the patient does not see the needle go into the arm nor the tubes of blood. The process takes about two minutes and has a 95% success rate on the first attempt.

Proscia is rewiring pathology to speed up the development of targeted therapies, accelerate diagnosis, and match more ...

The practice of drawing blood has changed very little over the decades. It looks about the same now as it did 50 years ago.

Trial results show vepdegestrant, a protein-degrading drug Arvinas is developing with Pfizer, improved on fulvestrant in a subgroup of breast cancer patients, but not the overall study population.

Patrick Lawrence (54), his wife Eileen (52), and sons Tom (24) and John (26), who were children at the time, made personal injury claims for road traffic accidents and falls using false names on ...

The firm is preparing for a trial to show the efficacy of its CyPath Lung test and support a submission to the US Food and Drug Administration for marketing clearance.